Ultrashort dual antiplatelet therapy (DAPT) following percutaneous coronary intervention for acute coronary syndrome is safe. A lower dose (5 mg) of prasugrel at 1 month led to lower bleeding rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback